As part of the Science x Media Tandem project “Research in Real Life – Exchange inspires schools,” funded by the Charité Foundation, Professor Il-Kang Na from the Berlin Institute of Health at Charité (BIH) explored new ways of making science tangible and accessible to young people, together with…
Organised by Prof. Ludovic Vallier’s research group at the Berlin Institute of Health at Charité (BIH), with Dylan Liabeuf, Anastasiia Maksiuk, Daniella Fradin and Katja Püstow leading the organisation, the second Berlin Organoid Symposium brought together over 220 international scientists at Bayer…
The Berlin Institute of Health at Charité (BIH) today launched a groundbreaking analytical platform that combines high-resolution 3D light microscopy, molecular genomic and proteomic analysis, and AI-driven evaluation. Developed in partnership with Roche Diagnostics, RoX Health, ZEISS, Bruker…
How well a bone heals after a fracture depends not only on individual cell types. The immediate environment in which these cells communicate with one another also plays a crucial role. A new study by researchers at the Berlin Institute of Health at Charité (BIH) shows how immune cells and bone cells…
The Oncovirtuous team, led by Dr. Anja Geisler, Leslie Kamstra, and Esther Horn, has set itself the goal of increasing the therapeutic efficacy of oncolytic viruses (OVs) following intravenous administration, thereby developing the next generation of cancer immunotherapy for the treatment of…
Knee osteoarthritis is one of the most common causes of chronic pain and disability worldwide. For many patients, conservative measures do not provide sufficient relief, while joint replacement is either not yet an option or not desired. For this large patient group, very few established treatment…
Dr. Milad Rezvani, principal investigator and alumnus of the BIH Charité Clinician Scientist Program “Excellence Track,” has been awarded the 2026 Science Award of the Society for Pediatric Gastroenterology and Nutrition (GPGE). The award ceremony took place on April 18 during this year’s GPGE…
On 23 April 2026, a total of eleven research groups opened their doors to give schoolgirls from across Berlin a fascinating insight into their work. Around 120 girls aged between 12 and 17 visited the Berlin Institute of Health (BIH) and Charité Universitätsmedizin Berlin, where they were able to…
The liver plays a central role in the body’s metabolism and immune regulation. Yet, many cellular mechanisms involved in liver diseases remain only partially understood. Researchers from Charité, Si-M – The Simulated Human and the Cincinnati Children’s Hospital Medical Center have now gained crucial…
BIH Professor Dr. Carsten Tschöpe received special recognition at the “HFA Winter Meeting on Translational Heart Failure Research” in Berlin. He delivered the prestigious Brutsaert Lecture to an international audience—an honor linked to a lifetime achievement award in translational cardiovascular…
The Berlin Institute of Health at Charité (BIH) is strengthening its research faculty in February with the appointments of Dr. Leif Si-Hun Ludwig and Dr. Daniel Ortmann. Ludwig has been awarded a prestigious Heisenberg professorship in stem cell dynamics and mitochondrial genomics, a position funded…
Researchers at Charité – Universitätsmedizin Berlin and the BIH Center for Regenerative Therapies (BCRT) have gained new insights into immune responses to therapeutic mRNAs. Here, senior author and study lead Dr. Norman Drzeniek answers questions about the research findings.
Researchers at the Berlin Institute of Health (BIH) at Charité, in collaboration with the technology firm Cellbricks, have developed a 3D printer capable of producing biological bandages. These custom-fit wound dressings are designed to seal large-scale injuries and could offer a transformative…
The Berlin Institute of Health at Charité (BIH) is strengthening its expertise in translational research with two new W2 professorships: Dr. Sven Geißler has been appointed Professor of “Biological Foundations of Musculoskeletal Regeneration,” and Dr. Daniel Ibrahim has been appointed Professor of…
Researchers from the Berlin Institute of Health at Charité (BIH) and the Max Planck Institute for Molecular Genetics, in collaboration with international colleagues, published a paper in Nature Genetics on a method to detect evolutionary conserved enhancers that diverged so much that their DNA…
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces,…
A study under the leadership of Prof. Leif Erik Sander has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. The results of the study have now been published in The Lancet Infectious Diseases.
On February 20 2025, the Julius Wolff Institute, the BIH Center for Musculoskeletal Biomechanics and Regeneration, celebrated the opening of its new research areas in the Rahel Hirsch Center for Translational Medicine (RHC). To mark this major step, the team honored Dr. Julius Wolff, the person…
A research team led by Prof. Dr. Georg Duda is endeavoring to innovate tissue engineering at the BIH Center for Regenerative Therapies (BCRT). In cooperation with industrial partner Cellbricks Therapeutics Inc., the team integrated a modern, light-based bioprinter that can produce these tissues by…
When the liver is damaged by chronic diseases, it has the ability to regenerate itself. Cancer, however, can develop during the regeneration process. A team of researchers led by Ludovic Vallier, Einstein Professor for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité…
Regulatory T cells (Treg) are a type of immune cell that can suppress harmful inflammation caused by autoimmune diseases or after organ transplants. As a living drug, they are promising for precision medicine, but until now it has been necessary to produce a specific cell product for each patient.…
Prof. Christian Gaebler, an HIV researcher at Charité – Universitätsmedizin Berlin, has a goal: to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, even without medications.
When bone fractures occur, there is a 10 to 15 percent chance that the fracture will not heal properly despite state-of-the-art surgical care. This complication, called pseudarthrosis, can often only be treated with several complicated follow-up surgeries. A study by scientists from the Berlin…
Scientists from the Berlin Institute of Health at Charité (BIH) and Open Targets together with colleagues from the University of Cambridge, and Addenbrooke’s Hospital in Cambridge, UK, uncovered mechanisms driving regeneration of the liver during chronic liver disease. This regenerative process…
The BoneGuide team is one step closer to making its transformative bone healing technology available to healthcare providers and patients alike. BoneGuide is a project of Charité - Universitätsmedizin Berlin and is supported by Charité BIH Innovation. On May 1, 2024, Aaron Herrera and his team…
The Berlin Institute of Health Center for Regenerative Therapies (BIH-CRT), Cluster Health Capital Berlin-Brandenburg, German Heart Center at Charité (DHZC) and Berlin Partner hosted the 10th RegMed Forum on November 23, 2023, at the Cranach Haus. The forum's primary objective was to engage various…
Univ. Prof. Dr Georg Duda was honoured by the DGU's Johann Friedrich Dieffenbach Bust on 23 October 2023 as part of the German Congress of Orthopaedics and Trauma Surgery (DKOU) 2023 for his special achievements to trauma surgery. The Dieffenbach Bust was established in 1982 as an honourable award…
The Swedish biotechnologist and biomedical scientist Johanna Bolander has been awarded a W1 professorship in Model Systems for Regenerative Therapies. She wants to simulate in the laboratory the processes that underlies failed musculoskeletal tissue repair. The long term goal with her research aims…
We already know in great detail how proteins are encoded in the DNA sequence of our genes. However, our understanding how one gene is active in one cell, but inactive in another is much more limited. While it's clear that the information for this gene activity is also “programmed” in DNA, we have…
Bone is the second most commonly transplanted tissue after blood, with about two million bone transplants performed worldwide each year – but often with only moderate therapeutic success. Cell-based therapies could provide an alternative approach to transplantation. Together with colleagues from…
The yearly RegMed Forum: “Will AI Transform Regenerative Medicine?” took place on December 1st, 2022 at the Berlin Institute for Medical Systems Biology, BIMSB organized under the scientific direction of the Berlin Institute of Health (BIH) Center for Regenerative Therapies (BCRT) (Tobias Winkler,…
Anomalies in the formation of blood and lymphatic vessels are, thankfully, rare. Those who do have them face a lifetime of complications that can range from the mild to the life-threatening. To date, little is known about the causes, which means the diagnostic and treatment options are very limited.…
The European Research Council (ERC) has awarded Professor Georg Duda of the Berlin Institute of Health at Charité (BIH) an ERC Advanced Grant worth €2.5 million. His sponsored project explores the budding field of immunomechanics, which studies how the immune system and tissue mechanics interact…
Effective July 1, 2022, Ludovic Vallier will take up the W3 Einstein Strategic Professorship for Stem Cells in Regenerative Therapies at the Berlin Institute of Health at Charité (BIH). Vallier is an expert in pluripotent stem cells and organoids. He uses these versatile cells to grow liver cells,…
Professor Carsten Tschöpe has been elected and appointed Chair of the Working Group: Myocardial and Pericardial Diseases. Already in January, his application to the DFG for funding was approved. And in early May, he received a research award from the Charité 2.0 program.
Prof. Leif Erik Sander and Prof. Martin Witzenrath took over joint direction of the Department of Infectious Diseases and Respiratory Medicine at Charité – Universitätsmedizin Berlin in April. In addition, Prof. Sander has become a Full Professor of Infectious Diseases at Charité and will head the…
Scientists at the Berlin Institute of Health at Charité (BIH) have teamed up with a company called Cellbricks to develop a 3D printer that can produce a biological wound closure: Using a mix of gelatin and skin cells, the device prints a perfectly fitting bandage that can be used to close large…
![[Translate to englisch:]](/fileadmin/_processed_/5/e/csm_CranachHaus_3f11a82ef5.webp "[Translate to englisch:]")